Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes.
第一作者:
R,Scott
第一单位:
Lipid and Diabetes Research Group, Christchurch School of Medicine, Christchurch, New Zealand.
作者:
医学主题词
方差分析(Analysis of Variance);血糖(Blood Glucose);体重(Body Weight);胆固醇, LDL(Cholesterol, LDL);糖尿病, 2型(Diabetes Mellitus, Type 2);双盲法(Double-Blind Method);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);人类(Humans);降血糖药(Hypoglycemic Agents);胰岛素(Insulin);脂类(Lipids);男(雄)性(Male);二甲双胍(Metformin);中年人(Middle Aged);吡嗪类(Pyrazines);噻唑烷二酮类(Thiazolidinediones);治疗结果(Treatment Outcome);三唑类(Triazoles);甘油三酯类(Triglycerides)
DOI
10.1111/j.1463-1326.2007.00839.x
PMID
18201203
发布时间
2024-12-19
- 浏览21
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



